Mutual of America Capital Management LLC Sells 1,773 Shares of Exponent, Inc. (NASDAQ:EXPO)

Mutual of America Capital Management LLC trimmed its holdings in shares of Exponent, Inc. (NASDAQ:EXPOFree Report) by 5.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,275 shares of the business services provider’s stock after selling 1,773 shares during the quarter. Mutual of America Capital Management LLC owned 0.06% of Exponent worth $2,753,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Asset Management One Co. Ltd. bought a new stake in shares of Exponent in the 4th quarter valued at $4,340,000. Fenimore Asset Management Inc. boosted its stake in shares of Exponent by 62.8% in the 4th quarter. Fenimore Asset Management Inc. now owns 172,868 shares of the business services provider’s stock valued at $15,219,000 after purchasing an additional 66,664 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in shares of Exponent by 261.7% in the 4th quarter. Assenagon Asset Management S.A. now owns 56,510 shares of the business services provider’s stock valued at $4,975,000 after purchasing an additional 40,886 shares during the last quarter. Natixis Advisors L.P. boosted its stake in shares of Exponent by 2.2% in the 3rd quarter. Natixis Advisors L.P. now owns 35,515 shares of the business services provider’s stock valued at $3,040,000 after purchasing an additional 767 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of Exponent by 3.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 466,940 shares of the business services provider’s stock valued at $39,970,000 after purchasing an additional 15,819 shares during the last quarter. 92.37% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Exponent news, insider Eric Guyer sold 3,367 shares of Exponent stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $78.49, for a total transaction of $264,275.83. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.20% of the company’s stock.

Exponent Stock Performance

Shares of NASDAQ EXPO opened at $78.12 on Friday. Exponent, Inc. has a fifty-two week low of $64.61 and a fifty-two week high of $101.65. The stock has a market cap of $3.95 billion, a price-to-earnings ratio of 40.06 and a beta of 0.68. The firm’s 50-day simple moving average is $79.30 and its 200 day simple moving average is $82.12.

Exponent (NASDAQ:EXPOGet Free Report) last announced its quarterly earnings results on Thursday, February 1st. The business services provider reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.03). Exponent had a net margin of 18.69% and a return on equity of 28.49%. The business had revenue of $113.87 million during the quarter, compared to the consensus estimate of $119.11 million. During the same period in the previous year, the business posted $0.44 EPS. Exponent’s revenue was up 1.1% compared to the same quarter last year. On average, sell-side analysts predict that Exponent, Inc. will post 1.76 EPS for the current year.

Exponent Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, March 8th were given a dividend of $0.28 per share. The ex-dividend date was Thursday, March 7th. This represents a $1.12 annualized dividend and a dividend yield of 1.43%. This is a boost from Exponent’s previous quarterly dividend of $0.26. Exponent’s dividend payout ratio (DPR) is currently 57.44%.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on EXPO. Truist Financial reduced their price objective on shares of Exponent from $110.00 to $95.00 and set a “buy” rating on the stock in a research note on Friday, February 2nd. StockNews.com upgraded shares of Exponent from a “sell” rating to a “hold” rating in a research report on Monday, March 4th.

Check Out Our Latest Analysis on Exponent

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.